IL13RA2 and glioblastoma: Li et al. used tandem CAR-T cells (TanCAR-T) targeting the HER2 and IL13Rα2 proteins for the treatment of glioblastomas and proved that they could address the problem of tumor antigen escape and increase the anti-tumor effect (Figure 3d) [79].